Advertisement

Evaluation of clinical disturbances of the hypothalamus

  • G. M. Besser

Abstract

Endocrine disturbances of hypothalamic function may affect those peptide hormones normally associated with either the anterior or posterior lobes of the pituitary gland. Alternatively such diseases may occur as a result of primary pituitary pathology (figure 7.1). The clinical management involves initial confirmation of the pituitary secretory disorder and then if possible the differentiation of the site of the lesion either at the hypothalamic or the pituitary level.

Keywords

Diabetes Insipidus Human Chorionic Gonadotrophin Thyrotrophin Release Hormone Urine Osmolality Growth Hormone Release 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anderson, D. C., Marshall, J. C., Young, J. L. and Fraser, T. R. (1972). Stimulation tests on pituitary-Leydig cell function in normal male subjects and hypogonadal men. Clin. EndocrinoL, 1, 127–140CrossRefGoogle Scholar
  2. Beardwell, C. G. and Wright, A. D. (1968). The radioimmunoassay of arginine-vasopressin. In C. Gual (ed.). International Congress Series, 157, Excerpta Medica, Amsterdam, 48Google Scholar
  3. Besser, G. M. (1974). Hypothalamus as an endocrine organ: Part I. Brit. Med. J., 3, 560–564CrossRefGoogle Scholar
  4. Besser, G. M., McNeilly, A. S., Anderson, D. C., Marshall, J. C., Harsoulis, P., Hall, R., Ormston, B. J., Alexander, L. and Collins, W. P. (1972a). Hormonal responses to synthetic luteinizing hormone and follicle stimulating hormone-releasing hormone in man. Brit. Med. J., 3, 267–271CrossRefGoogle Scholar
  5. Besser, G. M., Parke, L., Edwards, C. R. W., Forsythe, I. A. and McNeilly, A. S. (1972b). Galactorrhoea-successful treatment with reduction of plasma prolactin levels by Brom-ergocryptine. Brit. Med. J., 3, 669–672CrossRefGoogle Scholar
  6. Besser, G. M., Ratcliffe, J. G., Kilborn, J. B., Ormston, B. J. and Hall, R. (1971). Interaction between thyrotrophin, corticotrophin and growth hormone secretion in man. J. Endocrinol., 51, 699–706CrossRefGoogle Scholar
  7. Cain, J. P., Williams, G. H. and Dluhy, R. G. (1972). Glucagon-initiated human growth hormone release: a comparitive study. Can. Med., Ass. J., 107, 617–622Google Scholar
  8. Chard, T., Hudson, C. N., Edwards, C. R. W. and Boyd, N. R. H. (1971). Release of oxcytocin and vasopressin by the human foetus during labour. Nature, 234, 352–354CrossRefGoogle Scholar
  9. Cheng, K. W. and Friesen, H. G. (1971). A radioimmunoassay for vasopressin binding proteins neurophysin. Endocrinology, 88, 608–619CrossRefGoogle Scholar
  10. Chiodini, P. G., Liuzzi, A., Botalla, L., Cremascoli, G. and Silvestrini, F. (1974). Inhibitory effect of dopaminergic stimulation on GH release in acromegaly. J. Clin. EndocrinoL Metab., 38, 200–206CrossRefGoogle Scholar
  11. Dashe, A. M., Cramm, R. E., Crist, C. A., Habener, J. F. and Solomon, D. H. A. (1963). A water deprivation test for the differential diagnosis of polyuria. J. Am. Med. Ass., 185, 699–703CrossRefGoogle Scholar
  12. Edwards, C. R. W. and Besser, G. M. (1974). Diseases of the hypothalamus and pituitary gland. In R. I. S. Bayliss (ed.). Clinics in Endocrinology and Metabolism. 3, 475–505Google Scholar
  13. Edwards, C. R. W., Chard, T., Kitau, M. J. and Forsling, M. L. (1970). The development of a radioimmunoassay and a plasma extraction method for vasopressin. J. Endocrinol, 48, xi-xiiGoogle Scholar
  14. Edwards, C. R. W., Chard, T., Kitau, M. J., Forsling, M. L. and Landon, J. (1972). The development of a radioimmunoassay for arginine-vasopressin: production of antisera and labelled hormone; separation techniques; specificity and sensitivity of the assay in aqueous solution. J. Endocrinol., 52, 279–288Google Scholar
  15. Fawcett, C. T., Powell, A. E. and Sachs, H. (1968). Biosynthesis and release of neurophysin. Endocrinology, 83, 1299–1310CrossRefGoogle Scholar
  16. Ginsburg, M. and Ireland, M. (1963). The hormone-binding protein of the neurohypophysis. J. Physiol., 169, 15 PGoogle Scholar
  17. Greenwood, F. C., Landon, J. and Stamp, T. C. (1966). The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. Part I: in control subjects. J. Clin. Invest., 45, 429–436CrossRefGoogle Scholar
  18. Gwinup, G. (1965). Studies on the mechanism of vasopressin-induced steroid secretion in man. Metabolism, 14, 1282–1286CrossRefGoogle Scholar
  19. Hall, R., Ormston, B. J., Besser, G. M., Cryer, R. J. and McKendrick, M. (1972). The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet, i, 759–763CrossRefGoogle Scholar
  20. Hollenberg, M. D. and Hope, D. B. (1968). The isolation of the native hormone-binding proteins from bovine pituitary posterior lobes. Biochem. J., 106, 557–564CrossRefGoogle Scholar
  21. Jacobs, H. A. and Nabarro, J. D. (1969). Tests of hypothalamic-pituitary-adrenal function in man. Q. J. Med., 38, 475–491Google Scholar
  22. Jenkins, J. S. and Elkington, S. E. (1964). Metyrapone and pyrogen in the assessment of pituitary-adrenal function after removal of pituitary adenoma. Lancet, ii, 991–994CrossRefGoogle Scholar
  23. Klein, L. A., Roth, J. and Petersen, M. J. (1966). Radioimmunoassay of arginine vasopressin (antidiuretic hormone). S. Forum, 17, 240–242Google Scholar
  24. Landon, J., James, V. H. T. and Stoker, D. J. (1965). Plasma-cortisol reponse to lysinevasopressin. Lancet, ii, 1156–1159Google Scholar
  25. Legros, J. J., Franchimont, P. and Hendrick, J. C. (1969). Dosage radioimmunologique de la neurophysine dans le sérum des femmes normales et des femmes enceintes. C. R. Soc. Biot, 163, 2773–2777Google Scholar
  26. Liddle, G. W., Este, P. H. I., Kendall, J. W., Williams, W. C. and Towns, A. W. (1959). Clinical application of a new test of pituitary reserve. J. Clin. EndocrinoL Metab., 19, 875–894CrossRefGoogle Scholar
  27. Liuzzi, A., Chiodini, P. G., Botalla, L., Cremoscoli, G., Muller, E. E. and Silvestrini, F. (1972). Inhibitory effect of L-dopa on GH release in acromegalic patients. J. Clin. EndocrinoL Metab., 35, 941–943CrossRefGoogle Scholar
  28. Macleod, R. M. and Lehmeyer, J. E. (1974). Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion. Endocrinology, 94, 1077–1085CrossRefGoogle Scholar
  29. Marks, L. J., Berde, B., Klein, L. A., Roth, J., Goonan, S. R., Blumen, D. and Nabseth, D. C. (1968). Inappropriate vasopressin secretion and carcinoma of the pancreas. Am. J. Med, 45, 967–974CrossRefGoogle Scholar
  30. Martin, M. J., Chard, T. and Landon, J. (1972). The development of a radioimmunoassay for bovine neurophysin. J. Endocrinol., 52, 481–495CrossRefGoogle Scholar
  31. Miller, M., Dalakos, T., Moses, A. M., Fellerman, H. and Streeten, D. H. P. (1970). Recognition of partial defects in antidiuretic hormone secretion. Ann. Int. Med., 73, 721–729CrossRefGoogle Scholar
  32. Mitchell, M. L., Byrne, M. J., Sanchez, Y. and Sawin, C. T. (1970). Detection of growth-hormone deficiency. The glucagon stimulation test. New Engl. J. Med., 282, 539–541CrossRefGoogle Scholar
  33. Mortimer, C. H., Besser, G. M., McNeilly, A. S., Marshall, J. C., Harsoulis, P., Tunbridge, W. M. G., Gomez-Pan, A. and Hall, R. (1973a). Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic pituitary-gonadal dysfunction. Brit. Med. J., 4, 73–77CrossRefGoogle Scholar
  34. Mortimer, C. H., Besser, G. M., McNeilly, A. S., Tunbridge, W. M. G., Gomez-Pan, A. and Hall, R. (1973b). Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH/FSH-RH, TRH and hypoglycaemia alone and in combination. Clin. EndocrinoL, 2, 317–326CrossRefGoogle Scholar
  35. Mortimer, C. H., McNeilly, A. S. and Besser, G. M. (1976). Gonadotrophin releasing hormone therapy. Ann. Biol. Anim. Bloch. Biophys., 16, 235–243CrossRefGoogle Scholar
  36. Mortimer, C. H., McNeilly, A. S., Murray, M. A. F., Fisher, R. A. F. and Besser, G. M. (1974). Gonadotrophin-releasing hormone therapy in hypogonadal males with hypothalamic or pituitary dysfunction. Brit. Med. J., 4, 617–621CrossRefGoogle Scholar
  37. Ormston, B. J., Garry, R., Cryer, R. J., Besser, G. M. and Hall, R. (1971). Thyrotrophin releasing hormone as a thyroid-function test. Lancet, ii, 10–14Google Scholar
  38. Plumpton, F. S., Besser, G. M. and Cole, P. V. (1969). Corticosteroid treatment and surgery. Part I: An investigation of the indications for steroid cover. Anaesthesia, 24, 3–11CrossRefGoogle Scholar
  39. Price, J. D. E. and Lauener, R. W. (1966). Serum and urine osmolalities in the differentialGoogle Scholar
  40. diagnosis of polyuric states. J. Clin. EndocrinoL Metab. 26, 143–148Google Scholar
  41. Robertson, G. L., Klein, L. A., Roth, J. and Gorden, P. (1970). Immunoassay of plasma vasopressin in man. Proc. Natn., Acad. Sct, Washington, 66, 1298–1305CrossRefGoogle Scholar
  42. Schwartz, W. B., Bennett, W., Curelop, S. and Bartter, F. C. (1957). A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am. J. Med., 23, 529–542CrossRefGoogle Scholar
  43. Takahara, J., Arimura, A. and Schally, A. V. (1974). Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophyseal portal vessel. Endocrinology, 95, 462–465CrossRefGoogle Scholar
  44. Thorner, M. O. and Besser, G. M. (1977). Clinical significance of dopaminergic mechanisms in the hypothalamus and pituitary. In J. L. H. O’Riordan (ed.). Recent Advances in Endocrinology and Metabolism. Churchill Livingston, London, 1–17Google Scholar
  45. Thorner, M. O., Chait, A., Aitken, M., Benker, G., Bloom, S. R., Mortimer, C. H., Sanders, P., Stuart Mason, A. and Besser, G. M. (1975). Bromocryptine treatment of acromegaly. Brit. Med. J., 1, 299–303CrossRefGoogle Scholar
  46. Thorner, M. O., McNeilly, A. S., Hagan, C. and Besser, G. M. (1974). Long-term treatment of galactorrhoea and hypogonadism with bromocryptine. Brit. Med J., 2, 419–422CrossRefGoogle Scholar
  47. de Wardener, M. E. and Herxheimer, A. W. (1957). The effect of a high water intake on the kidney’s ability to concentrate the urine in man. J. Physiol., 139, 42–52CrossRefGoogle Scholar
  48. Wass, J. A. H., Thorner, M. O., Morris, D. V., Rees, L. H., Stuart Mason, A., Jones, A. E. and Besser, G. M. (1977). Long-term treatment of acromegaly with bromocryptine. Brit. Med J., 1, 875–878CrossRefGoogle Scholar

Copyright information

© B. Cox, I. D. Morris and A. H. Weston 1978

Authors and Affiliations

  • G. M. Besser
    • 1
  1. 1.Department of Endocrinology, University of LondonSt. Bartholomew’s Hospital Medical CollegeLondonUK

Personalised recommendations